Pharmafile Logo

COUCH Medcomms

- PMLiVE

AbbVie to expand immunology pipeline with $200m Nimble Therapeutics acquisition

The deal includes an IL23R inhibitor in preclinical development for psoriasis and inflammatory bowel disease

- PMLiVE

GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use

Approximately 121,000 people are diagnosed with primary advanced or recurrent endometrial cancer each year in Europe

- PMLiVE

Eli Lilly’s Omvoh recommended by CHMP to treat Crohn’s disease in adults

The drug is already approved in the EU to treat ulcerative colitis, another form of inflammatory bowel disease

- PMLiVE

Is omnichannel right for rare diseases?

By Emma Warnants and Chloe Zentai

- PMLiVE

Sanofi’s BTK inhibitor tolebrutinib granted FDA breakthrough designation for MS

The neurological disorder affects approximately 2.9 million people globally

EU flag

CHMP recommends Galderma’s nemolizumab for atopic dermatitis and prurigo nodularis

The drug has been recommended for use in patients with moderate-to-severe cases of the skin diseases

- PMLiVE

Gilead appoints Dietmar Berger as chief medical officer

Berger most recently served as chief medical officer and global head of development at Sanofi

- PMLiVE

The need for a human touch in an AI world

AI is shooting for the moon and the stars but the real benefits come from anchoring it to the human voice

- PMLiVE

AbbVie’s Parkinson’s disease candidate tavapadon shows promise in phase 3 trial

More than ten million people worldwide are living with the neurodegenerative disorder

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links